1. Home
  2. AMG vs CORT Comparison

AMG vs CORT Comparison

Compare AMG & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Affiliated Managers Group Inc.

AMG

Affiliated Managers Group Inc.

SELL

Current Price

$388.97

Market Cap

9.9B

Sector

Finance

ML Signal

SELL

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

SELL

Current Price

$69.12

Market Cap

9.7B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
AMG
CORT
Founded
1993
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.9B
9.7B
IPO Year
1997
2001

Fundamental Metrics

Financial Performance
Metric
AMG
CORT
Price
$388.97
$69.12
Analyst Decision
Strong Buy
Buy
Analyst Count
7
5
Target Price
★ $466.71
$142.60
AVG Volume (30 Days)
304.6K
★ 1.2M
Earning Date
11-09-2026
11-03-2026
Dividend Yield
★ 0.01%
N/A
EPS Growth
★ 50.30
N/A
EPS
★ 17.38
1.13
Revenue
★ $2,074,400,000.00
$761,407,000.00
Revenue This Year
$17.42
$52.09
Revenue Next Year
$9.39
$44.73
P/E Ratio
★ $22.70
$64.68
Revenue Growth
1.64
★ 12.79
52 Week Low
$246.11
$28.66
52 Week High
$408.07
$126.38

Technical Indicators

Market Signals
Indicator
AMG
CORT
Relative Strength Index (RSI) 52.16 23.43
Support Level $340.19 $30.24
Resistance Level $396.01 $122.93
Average True Range (ATR) 15.28 4.57
MACD 1.14 -0.32
Stochastic Oscillator 64.06 1.07

Price Performance

Historical Comparison
AMG
CORT

About AMG Affiliated Managers Group Inc.

Affiliated Managers Group offers investment strategies to investors through its network of affiliates. The firm typically buys a majority interest in small to mid-size boutique asset managers, receiving a fixed percentage of revenue from these firms in return. Affiliates operate independently, with AMG providing strategic, operational, and technology support, as well as global distribution. At the end of June 2026, AMG's affiliate network—which includes firms like Abacus Capital and Pantheon dedicated to private markets (which accounted for 16% of AUM), AQR Capital and Capula Investment Management in liquid alternatives (31%), and Harding Loevner, Tweedy Browne, Parnassus, and Yacktman in equities, multi-asset, and bond strategies (53%)—had $942.4 billion in managed assets.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.

Share on Social Networks: